PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 38 filers reported holding PROTARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,290,215 | -30.1% | 772,584 | 0.0% | 0.03% | -18.2% |
| Q2 2023 | $1,846,476 | -25.7% | 772,584 | -2.6% | 0.03% | -32.7% |
| Q1 2023 | $2,483,837 | +11.6% | 793,558 | -4.5% | 0.05% | +14.0% |
| Q4 2022 | $2,226,118 | -9.5% | 830,641 | 0.0% | 0.04% | -6.5% |
| Q3 2022 | $2,459,000 | +1.0% | 830,641 | 0.0% | 0.05% | +4.5% |
| Q2 2022 | $2,434,000 | -42.7% | 830,641 | 0.0% | 0.04% | -36.2% |
| Q1 2022 | $4,245,000 | -24.3% | 830,641 | 0.0% | 0.07% | -4.2% |
| Q4 2021 | $5,607,000 | +80.1% | 830,641 | +84.6% | 0.07% | +111.8% |
| Q3 2021 | $3,114,000 | -29.0% | 450,000 | 0.0% | 0.03% | -22.7% |
| Q2 2021 | $4,383,000 | -38.1% | 450,000 | 0.0% | 0.04% | -33.3% |
| Q1 2021 | $7,083,000 | -35.0% | 450,000 | 0.0% | 0.07% | -30.5% |
| Q4 2020 | $10,895,000 | +43.8% | 450,000 | 0.0% | 0.10% | 0.0% |
| Q3 2020 | $7,574,000 | – | 450,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $8,077,883 | 2.42% |
| Privium Fund Management (UK) Ltd | 119,730 | $401,096 | 0.32% |
| Ikarian Capital, LLC | 188,664 | $584,859 | 0.13% |
| Orbimed Advisors | 793,558 | $2,483,837 | 0.05% |
| Boxer Capital, LLC | 209,227 | $655 | 0.03% |
| Perceptive Advisors | 290,051 | $907,860 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $198,400 | 0.01% |
| Baker Brothers Advisors | 199,671 | $624,970 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $59,044 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 35,745 | $111,882 | 0.00% |